sunliquid Technology Proven and Ready for Commercial ...

16
ABLC 2015 - Washington, DC Clariant Biotech & Renewables Center sunliquid ® Technology Proven and Ready for Commercial Deployment

Transcript of sunliquid Technology Proven and Ready for Commercial ...

ABLC 2015 - Washington, DC

Clariant Biotech & Renewables Center

sunliquid® Technology Proven and Ready for Commercial Deployment

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 2

Employees 2013

18 099

Business Areas

EBITDA 2013 (CHF m)

before exceptionals

14.1%

Net result 2013 (CHF m)

from continuing operations

Sales 2013 (CHF m)

from continuing operations

A globally leading company in specialty chemicals

Clariant focuses on creating value

through innovation and sustainability.

6 076

858 EBITDA margin 2013

before exceptionals

323

4

Corporate Center, Pratteln, Switzerland

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 3

Clariant worldwide

More than 100 Group

companies worldwide

Over 200

production sites

Represented in

over 60 countries

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 4

Clariant’s portfolio offers a wide range of specialty chemicals

Care

Chemicals

Catalysis

& Energy

Natural

Resources

Plastics

& Coatings

SALES

(CHF m) 1 561

EBITDA** (CHF m) 263

EBITDA

MARGIN** 16.8%

*Results full year 2013

**Before exceptional items, as reported

SALES

(CHF m) 713

EBITDA** (CHF m) 159

EBITDA

MARGIN** 22.3%

SALES

(CHF m) 1 281

EBITDA** (CHF m) 195

EBITDA

MARGIN** 15.2%

SALES

(CHF m) 2 521

EBITDA** (CHF m) 356

EBITDA

MARGIN** 14.1%

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 5

Munich & Straubing – the two Biotech & Renewables sites

Munich

Since 2006

95 employees

Main Research & Development Center

Lab and office space: 3,300 m²

Pilot plant since 2009

Straubing

Since 2011

22 employees

sunliquid demonstration plant

Area: 2,500 m²

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

Clariant’s Biotechnology platform offers holistic solutions for bio-based products and processes

6

System

solutions out of

one hand

Catalysts

Bio-technology

Chemistry & Materials

Process Technology

Strain

collection

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

Process solutions in the industry are trying to integrate technology from multiple providers

7

System

solutions out of

one hand

Catalysts

Bio-technology

Chemistry & Materials

Process Technology

Strain

collection

Competitor A

Competitor B

Competitor C

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

With its focus on integration, sunliquid® is designed to achieve optimal efficiency

8

Bio-

technology

Process

Design

Enzymatic hydrolysis

High sugar yields through

feedstock and process-specific

cellulase enzymes

Integrated on-site enzyme

production with biomass as

nutrient source

Standard equipment

Low scale-up risk due to

established equipment

Standard protocols for plant and

equipment operations

Integrated

Technology

Solution

Low OPEX through process design and efficient conversion

Reduced CAPEX risk

Flexible feedstock input and product output

Ethanol Fermentation

High ethanol yields with

proprietary high-end yeast

technology

Simultaneous one-pot C5&C6

fermentation

Energy integration

Side products (e.g., Lignin) as

energy sources

Integration with site-specific energy

infrastructure

Thermal pre-treatment

Chemical-free & low-cost pre-

treatment

Conditions optimized jointly with

enzyme production

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

Clariant’s chemicals-free pretreatment is flexible and reduces OPEX

9

Clariant’s low-opex pre-treatment

Chemicals-free mild conditions steam-based

pretreatment

‒ Reduced operation cost, no acid or base

required leading to 45% less overall chemical

costs

‒ Reduced health risk from chemicals handling

Optimized conditions for multiple feedstocks

‒ Wheat Straw1

‒ Corn Stover1

‒ Bagasse1

‒ Long list of other feedstock tested in lab and

pilot plant2

Pre-treated raw material used for screening for

optimized enzymes strains

Hardware technology based on standard equipment

from the Paper & Pulp industry

1 Optimized at Clariant’s demonstration plant in Straubing

2 E.g., Cane Straw, woody biomass (hard and soft), empty fruit bunches, risk husks, rice straw, oat hulls, energy crops, etc.

3 Cost of total chemicals required for process (excl. enzyme production) in case pre-treatment with acid vs. chemical-free pretreatment is used

Sugar cane bagasse

Wheat straw

Chemicals-free Acid based

-45%

Overall chemicals cost3

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

Clariant’s enzymes are high-performing and cost-saving

10

1 Results were performed on chemical-free pre-treated biomass using standard hydrolysis conditions (identical enzyme concentrations)

2 Commercial enzymes from a leading enzyme provider for cellulytic enzymes (externally produced, purified and formulated for shipment)

Commercial

benchmark2

Lower cost

Higher cost

On-site biomass as

nutrient source

Not required,

whole broth used

for hydrolysis

Produced on-site

Standard enzymes

Expensive synthetic

nutrient source

required

Required for

stabilization

Produced off-site,

Transport required

Chemicals and

energy required

Nutrients

Purification

Formulation

Transport

Clariant’s enzymes show better performance

Clariant’s has established the efficient process of

Selection & Optimization & Screening to

develop and the best strain and activities

Clariant’s integrated on-site enzyme production reduces

cost by cutting out required processing steps and transport

Integration also enables feedstock specificity

Self-sufficiency from external supplier and logistics

Clariant’s enzymes perform better… …and reduce cost through integrated on-site production

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

The sunliquid® demonstration plant

11

Output: 1,000 t/a Ethanol

Location: Straubing, Germany

Operational since July 2012

Feedstock: ~ 4,500 t/a wheat

straw, corn stover or bagasse

Scale-up towards commercial

scale only 50x

Wheat Straw, Corn Stover, and

Sugarcane Bagasse converted

to Ethanol

Commercial-scale design

confirmed

Scale-up experience from pilot

plant and solution finding

sunliquid® demo plant

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

sunliquid® is being successfully tested as E20 blend

12

Since January 2014, sunliquid®20 is being tested in Mercedes’ fleet

Gasoline-Ethanol blend containing 20% cellulosic ethanol from Clariant’s demonstration plant

Joint Press Announcement on September 23

4% reduction in energy content through increased engine efficiency compared to E10 –> high quality fuel

with high octane!

Particle emissions are decreased by 50%

Advanced and sustainable! High GHG emission savings through cellulosic ethanol

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 13

For a 50 kt/a plant, a footprint of

approx. 14-18 acres is required

PDP ready for commercial-scale plant

Confidential information

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

Cellulosic

Ethanol

sunliquid® is the ideal technology platform for highly sustainable bio-based products

14

sunliquid® sunliquid®

Catalytic conversion sunliquid®

Sugar platform standalone

Development opportunities for

biobased products

Extensive know-how in

biocatalysis, strain optimization

and heterogenous catalysis

Biotechnology

Catalytic conversion

Biotechnology Bio-based

chemicals

Catalytic

conversion Cellulosic

Sugars

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

Clariant sunliquid® cellulosic ethanol links with JV partner Scientific Design

15

Ethanol Ethylene

Key facts about Scientific Design

50:50 Joint Venture between Clariant and SABIC

Licenser of Ethylene Oxide/Ethylene Glycol Technology (SD awarded ~80% of non-captive

licenses since 1980 with 30 licenses since 1990)

Licenser of alcohol dehydration technology (SD awarded two ethanol-to-ethylene and six

ethanol to EO/EG licenses since 2006)

Integration study has been completed between sunliquid technology & SD downstream

conversion to bio-MEG (including site retrofit and capital estimates)

ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015

For further information please contact:

Martin A. Mitchell

Global Business Development Manager

Group Biotechnology, Biofuels & Derivatives

Clariant Corporation

309 Court Avenue

Des Moines, Iowa 50309 USA

Phone: +515 699 8518

E-mail: [email protected]

For more information on sunliquid® technology visit www.sunliquid.com

16